Pharmaceutical giants are making headlines again, but this time, it's not about new drugs. Merck and eight other big players have joined Pfizer, Lilly, and Novo in signing Most Favored Nation (MFN) deals. These agreements aim to make medicines more affordable by tying drug prices to the lowest price
Pharmaceutical stocks have been overlooked for years. But now, AI is changing the game. It can speed up drug development. This could cut the time from 15 years to just 6. That's big news for the industry. Two companies stand out. Becton Dickinson (BDX) and the BlackRock Health Sciences Fund (BME).
Advanced biliary tract cancer is a serious condition that often requires a combination of treatments. One such treatment involves chemo-immunotherapy with gemcitabine, cisplatin, and durvalumab, followed by maintenance therapy with just durvalumab. The question is, who benefits most from this mainte
Advanced stomach cancer patients often struggle to eat enough food. This can lead to malnutrition. Doctors sometimes use a feeding tube to help. This method is not always used, even when guidelines suggest it. A recent study looked at how this feeding method affects these patients' nutrition, su
Advanced biliary tract cancer (BTC) is a tough nut to crack. Doctors often turn to second-line treatments like 5-fluorouracil (5FU) and liposomal irinotecan when first-line therapies fail. These drugs have shown promise in improving survival rates. But what if we could make them even more effective?
Advanced MRI techniques like MP2RAGE-FLAWS are shaking things up in the medical world. Originally, doctors relied on T2-w fat-saturated (FS) TSE imaging to spot optic nerve (ON) demyelination in multiple sclerosis patients. But guess what? MP2RAGE-FLAWS can detect brain and spine demyelinating issue
Advanced neuroblastoma, specifically stages 4 and 4S, is a childhood cancer that often has a grim outlook. Despite extensive studies, scientists haven't found any easily treatable gene issues. Surprisingly, stage 4S sometimes disappears on its own, making researchers think understanding the differen
